U.S. markets open in 51 minutes
  • S&P Futures

    4,026.00
    -6.50 (-0.16%)
     
  • Dow Futures

    33,730.00
    -55.00 (-0.16%)
     
  • Nasdaq Futures

    11,930.25
    -37.75 (-0.32%)
     
  • Russell 2000 Futures

    1,893.60
    +0.10 (+0.01%)
     
  • Crude Oil

    77.26
    -0.64 (-0.82%)
     
  • Gold

    1,927.30
    -11.90 (-0.61%)
     
  • Silver

    23.36
    -0.37 (-1.57%)
     
  • EUR/USD

    1.0861
    +0.0005 (+0.04%)
     
  • 10-Yr Bond

    3.5330
    -0.0180 (-0.51%)
     
  • Vix

    20.21
    +1.70 (+9.18%)
     
  • GBP/USD

    1.2324
    -0.0030 (-0.24%)
     
  • USD/JPY

    130.0150
    -0.3430 (-0.26%)
     
  • BTC-USD

    22,979.31
    -127.13 (-0.55%)
     
  • CMC Crypto 200

    521.06
    -16.81 (-3.12%)
     
  • FTSE 100

    7,741.25
    -43.62 (-0.56%)
     
  • Nikkei 225

    27,327.11
    -106.29 (-0.39%)
     

Why Shares of Agenus Rose 12.5% on Friday

Why Shares of Agenus Rose 12.5% on Friday

Shares of Agenus (NASDAQ: AGEN) rose 12.5% on Friday. One big buyer was Values First Advisors, a financial advisory firm that bought 10,013 shares of the company and now owns 238,514 shares of Agenus. Agenus focuses on immuno-oncology therapies that boost the body's ability to fight cancer and infections by activating T-cell immune responses.